COMMUNIQUÉS West-GlobeNewswire

Annual General Meeting of Active Biotech AB

18/05/2018 - 08:31

PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 17, 2018. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid. The board members and the [...]

Shire plc : Rule 2.9 Announcement

18/05/2018 - 08:01

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 18 May 2018 Shire [...]

Curetis Publishes Business and Financial Update for the First Quarter 2018

18/05/2018 - 07:03

Curetis Publishes Business and Financial Update for the First Quarter 2018 - Received U.S. FDA clearance for Unyvero System and LRT Cartridge - Grew revenues in EMEA direct selling markets by 518% vs Q1 2017 - Closed [...]

Adverum Biotechnologies Presents Additional Long-term Preclinical Data on ADVM-022 in Wet AMD at ASGCT 21st Annual Meeting

18/05/2018 - 02:15

-- Single Intravitreal Administration of Gene Therapy ADVM-022 Provides Long-term Protection in Nonhuman Primate Model of Wet AMD -- MENLO PARK, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. ( [...]

MBI Distributing, Inc. Issues Voluntary Nationwide Recall of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir due to a lack of process controls

18/05/2018 - 02:00

LINDON, Utah, May 17, 2018 (GLOBE NEWSWIRE) -- MBI Distributing, Inc. is voluntarily recalling all lots of homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver- [...]

Novartis and Amgen announce FDA approval of Aimovig(TM) (erenumab), a novel treatment developed specifically for migraine prevention

18/05/2018 - 01:18

Migraine is a severe neurologic disease that profoundly impacts millions of patients in the United States Aimovig is the first and only FDA-approved treatment to block the calcitonin gene-related peptide receptor (CGRP- [...]

Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting

18/05/2018 - 00:15

VY-SOD101 achieves meaningful suppression of disease-causing gene of ALS in large mammals after a one-time administration Results during the second half of 2018 from further delivery optimization efforts with VY-SOD101 [...]

Kane Biotech Announces First Quarter 2018 Financial Results, Granting of Options and Investor Relations Improvements

17/05/2018 - 23:30

WINNIPEG, Manitoba, May 17, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its First Quarter 2018 Financial Results, granting of options and [...]

VA, Cerner Announce Agreement to Provide Seamless Care for Veterans

17/05/2018 - 23:13

WASHINGTON, May 17, 2018 (GLOBE NEWSWIRE) -- Today the Department of Veterans Affairs (VA) announced an agreement with Cerner Government Services, Inc., a wholly owned subsidiary of Cerner Corporation, a global leader [...]

Celiac Disease KOL and Management Meetings around the Digestive Disease Week (DDW) conference on Monday, June 4, 2018, in Washington, D.C.

17/05/2018 - 21:06

RALEIGH, N.C., May 17, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT ), a clinical stage biotechnology company focused on developing novel therapeutics for immuno-inflammatory [...]

ELSALYS BIOTECH lance son introduction en Bourse sur le marché Euronext Growth® Paris

17/05/2018 - 21:03

Offre au public d'un montant brut de 15 M€ [a] pouvant être porté à environ 19,8 M€ en cas d'exercice intégral de la clause d'extension et de l'option de surallocation (l' « Offre ») Fourchette indicative de prix : [...]

ToolGen, Inc., Demonstrates CRISPR/cas9 Gene Editing Improves Anti-Tumor Activity of Human CAR-T Cells

17/05/2018 - 20:48

Knockout of T-Cell suppression pathway improves T-cell anti-tumor activity in a mouse glioblastoma model Data Presented at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting SEOUL, South Korea, May [...]

CorVel Announces Fiscal Earnings Release Webcast

17/05/2018 - 19:55

IRVINE, Calif., May 17, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL ) fiscal year earnings release, CorVel will stream a webcast over the Internet on Thursday, May 31st at 11:30 am [...]

Nohla Announces EHA Abstract Acceptance on Dilanubicel (NLA101) Off-the-Shelf Cell Therapy Showing Excellent Long-term Survival Outcomes

17/05/2018 - 19:00

86% Disease-Free and Overall Survival Rates in Dilanubicel Patients Five Years After Cord Blood Transplantation SEATTLE, May 17, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the- [...]

Reducing Health Care Provider Stress and Burnout to Improve Satisfaction and Patient Care

17/05/2018 - 19:00

New Articles in May 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., May 17, 2018 (GLOBE NEWSWIRE) -- Reducing health care provider stress and burnout to improve [...]

La Jolla Pharmaceutical Company Announces LJPC-401 Presentations at 23rd Congress of the European Hematology Association

17/05/2018 - 19:00

SAN DIEGO, May 17, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ), a leader in the discovery, development and commercialization of innovative therapies intended to significantly improve [...]

Medifirst Solutions Launches Specialty Prescription Billing and Pharmacy Solutions Division

17/05/2018 - 18:42

FREEHOLD, NJ, May 17, 2018 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

OSE Immunotherapeutics to Present at 4th Annual Immuno-Oncology: BD&L and Investment Forum

17/05/2018 - 18:00

Forum to be held in Chicago, IL, on June 1, 2018 NANTES, France, May 17, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE) today announces that Alexis Peyroles, chief executive officer, [...]

Aptose to Present New CG’806 Data at the 23rd Congress of the European Hematology Association

17/05/2018 - 17:43

SAN DIEGO and TORONTO, May 17, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting [...]